Specific immunotherapy in Albanian patients with anaphylaxis to hymenoptera venoms

Springer Science and Business Media LLC - Tập 2 - Trang 1-6 - 2002
Ervin Mingomataj1,2, Alfred Priftanji1, Etleva Qirko1, Q Thai Dinh2, Axel Fischer2, Christian Peiser2, David A Groneberg2
1Dept. of Allergy, Mother Theresa School of Medicine, University of Tirana, Tirana, Albania
2Division of Allergy Research, Dept. of Pediatric Pneumology and Immunology, Charité School of Medicine, Humboldt-University, Berlin, Germany

Tóm tắt

Severe allergic reactions during rush-specific immunotherapy (Rush-SIT) may occur in the treatment of hymenoptera sting allergy. The objective of the present study was to examine the characteristics of allergic reactions during Rush-SIT in a cohort of patients with allergy towards hymenoptera venom in the mediterranean population of Albania. A retrospective study was performed using the clinical reports of 37 patients with venom of bee (apinae), wasp (vespidae, subfamily vespinae) or paperwasp (vespidae, subfamily polistinae) allergy treated with Rush-SIT between 1987 and 1996. After hymenoptera sting allergy diagnosis according to anamnesis and intracutaneous tests the patient were treated with Rush-SIT. The protocol lasted 3 – 4 d with an increase in the concentration from 0.01 μg/ml to 100 μg/ml. Anaphylactic reactions were classified according to the Mueller-classification. The frequency of reactions during Rush-SIT for bee-venom was 4.7% and for wasp-venom was 1.5% (p < 0.01). The mean frequency of reactions of Mueller grade II for the bee-venom Rush-SIT patients during the first 4 d (= 26 injections) was 0.73 and for the wasp-venom Rush-SIT patients 0.15. No patient experienced a third-degree reaction. 94.6% of the patient supported an end dose of 100 μg. Rush-SIT is a reliable method for the treatment of anaphylactic reactions to hymenoptera venom even in less developed countries. Bee-venom Rush-SIT was found to cause higher numbers allergic reactions than wasp or paperwasp Rush-SIT.

Tài liệu tham khảo

Mosbech H: Death caused by wasp and bee stings in Denmark 1960–1980. Allergy 1983, 38: 195–200. Barnard JH: Studies of 400 Hymenoptera sting deaths in the United States. J Allergy Clin Immunol 1973, 52: 259–264. Georgitis J, Reisman R: Venom skin tests in insect-allergic and insect-nonallergic populations. J Allergy Clin Immunol 1985, 76: 803–807. Müller U, Mosbech H, Blaauw P, Dreborg S, Malling H, Przybilla B, Urbanek R, Pastorello E, Blanca M, Bosquet J, Jarisch R, Youlten L: Emergency treatment of allergic reactions to hymenoptera stings. Clin Exp Allergy 1991, 21: 281–288. Valentine M, Schuberth K, Sobotka A, Graft D, Kwiterovich K, Szklo M, Lichtenstein L: The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 1990, 323: 1601–1603. Golden DB, Marsh DG, Kagey-Sobotka A, Freidhoff L, Szklo M, Valentine MD, Lichtenstein LM: Epidemiology of insect venom sensitivity. JAMA 1989, 262: 240–244. 10.1001/jama.262.2.240 McGain F, Harrison J, Winkel KD: Wasp sting mortality in Australia. Med J Aust 2000, 173: 198–200. Molina C: Acquisitions récentes sur l'allergie aux hyménoptères. Immunol médicale 1985, 10: 67–71. Reisman R: Insect stings. N Engl J Med 1994, 331: 523–527. 10.1056/NEJM199408253310808 Rueff F, Reissig J, Przybilla B: Side effects of rush hyposensitization with hymenoptera venoms. Allergo J 1997, 6: 59–64. Mueller HL: Insect allergy. Pediatr Clin North Am 1959, 6: 917–952. Cohen SG: The pharaoh and the wasp. Allergy Proc 1989, 10: 149–151. Hunt KJ, Valentine MD, Sobotka AK, Benton AW, Amodio FJ, Lichtenstein LM: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978, 299: 157–161. Golden DB, Schwartz HJ: Guidelines for venom immunotherapy. J Allergy Clin Immunol 1986, 77: 727–728. Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC: The Hymenoptera venom study. III: Safety of venom immunotherapy. J Allergy Clin Immunol 1990, 86: 775–780. Mosbech H, Malling HJ, Biering I, Bowadt H, Soborg M, Weeke B, Lowenstein H: Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986, 41: 95–103. Bousquet J, Muller UR, Dreborg S, Jarisch R, Malling HJ, Mosbech H, Urbanek R, Youlten L: Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology. Allergy 1987, 42: 401–413. Reisman RE, Livingston A: Late-onset allergic reactions, including serum sickness, after insect stings. J Allergy Clin Immunol 1989, 84: 331–337. Reisman RE, Livingston A: Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance doses. J Allergy Clin Immunol 1992, 89: 1189–1195. Reisman RE: Duration of venom immunotherapy: relationship to the severity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 1993, 92: 831–836. Rueff F, Przybilla B, Muller U, Mosbech H: The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 1996, 51: 216–225. Laurent J, Smiejan JM, Bloch-Morot E, Herman D: Safety of Hymenoptera venom rush immunotherapy. Allergy 1997, 52: 94–96. Hoffman DR, Wood CL: Allergens in Hymenoptera venom XI. Isolation of protein allergens from Vespula maculifrons (yellow jacket) venom. J Allergy Clin Immunol 1984, 74: 93–103. Valentine MD: Insect venom allergy: diagnosis and treatment. J Allergy Clin Immunol 1984, 73: 299–304. Berchtold E, Maibach R, Muller U: Reduction of side effects from rush-immunotherapy with honey bee venom by pretreatment with terfenadine. Clin Exp Allergy 1992, 22: 59–65. Westall GP, Thien FC, Czarny D, O'Hehir RE, Douglas JA: Adverse events associated with rush hymenoptera venom immunotherapy. Med J Aust 2001, 174: 227–230. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-5945/2/11/prepub